お知らせ • Feb 27
SLS BIO Co., Ltd, Annual General Meeting, Mar 27, 2026 SLS BIO Co., Ltd, Annual General Meeting, Mar 27, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 145, gwanggyo-ro, yeongtong-gu, gyeonggi-do, suwon South Korea New Risk • May 09
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (9.7% average weekly change). Market cap is less than US$100m (₩28.9b market cap, or US$20.7m). お知らせ • Feb 28
SLS BIO Co., Ltd, Annual General Meeting, Mar 25, 2025 SLS BIO Co., Ltd, Annual General Meeting, Mar 25, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 145, gwanggyo-ro, yeongtong-gu, gyeonggi-do, suwon South Korea お知らせ • Oct 03
SLS BIO Co., Ltd (KOSDAQ:A246250) announces an Equity Buyback for KRW 900 million worth of its shares. SLS BIO Co., Ltd (KOSDAQ:A246250) announces a share repurchase program. Under the program, the company will repurchase up to KRW 900 million worth of its shares pursuant to a trust agreement with Daeshin Securities. The purpose behind the program is to stabilize the stock price and to enhance shareholder value. The program will continue until April 2, 2025. As of October 1, 2024, the company had no shares in treasury through buyback within dividend capacity or through other acquisitions. New Risk • Jul 26
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩55.7b market cap, or US$40.2m). New Risk • Dec 04
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risk Market cap is less than US$100m (₩36.9b market cap, or US$28.3m). New Risk • Jul 04
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (8.3% average weekly change). Market cap is less than US$100m (₩72.0b market cap, or US$55.4m). お知らせ • Mar 16
SLS BIO Co., Ltd, Annual General Meeting, Mar 30, 2021 SLS BIO Co., Ltd, Annual General Meeting, Mar 30, 2021, at 10:30 Korea Standard Time. Is New 90 Day High Low • Jan 22
New 90-day low: ₩10,100 The company is down 12% from its price of ₩11,500 on 23 October 2020. The South Korean market is up 32% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Life Sciences industry, which is up 23% over the same period. Is New 90 Day High Low • Nov 05
New 90-day low: ₩10,800 The company is down 17% from its price of ₩13,000 on 07 August 2020. The South Korean market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Life Sciences industry, which is down 5.0% over the same period.